Natural Capsules Ltd
BSE:524654
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Natural Capsules Ltd
Operating Income
Natural Capsules Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Natural Capsules Ltd
BSE:524654
|
Operating Income
-₹135.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹63.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹53.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹135.6B
|
CAGR 3-Years
42%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Operating Income
₹59.6B
|
CAGR 3-Years
147%
|
CAGR 5-Years
32%
|
CAGR 10-Years
8%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹33.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
Natural Capsules Ltd
Glance View
Natural Capsules Ltd. engages in the manufacture of capsules. The company is headquartered in Bangalore, Karnataka. The firm manufactures hard gelatin capsule shells, hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage format. The company is also engaged in formulating the pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products. Its product offerings include hard gelatin capsule shells, bovine spongiform encephalopathy (BSE)/transmissible spongiform encephalopathy (TSE) free gelatin capsule shells, shiny gelatin capsule shells, sodium lauryl sulphate (SLS) free gelatin capsule shells, halal certified gelatin capsule shells, fortified gelatin capsule shells, sweet gelatin capsule shells, fast release gelatin capsule shells, printed gelatin/cellulose capsule shells, vegetarian capsule shells and enteric capsule shells. The company provides turnkey solutions to all of its customers. The firm's manufacturing plants are located at Bangalore and Pondicherry.
See Also
What is Natural Capsules Ltd's Operating Income?
Operating Income
-135.3m
INR
Based on the financial report for Dec 31, 2025, Natural Capsules Ltd's Operating Income amounts to -135.3m INR.
